The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Trends in use of ovarian suppression (OS) for premenopausal patients with early-stage hormone positive breast cancer and Intermediate Risk (IR) Oncotype Recurrence Scores (RS) from 2006-2020: A retrospective database analysis.
 
Sara Malin Hovstadius
No Relationships to Disclose
 
Brittney Shulman Zimmerman
No Relationships to Disclose
 
Shana Berwick
No Relationships to Disclose
 
Julia Blanter
No Relationships to Disclose
 
Natalie F Berger
No Relationships to Disclose
 
Erin Moshier
No Relationships to Disclose
 
Asem Berkalieva
No Relationships to Disclose
 
Shabnam Jaffer
No Relationships to Disclose
 
Krystal Pauline Cascetta
No Relationships to Disclose
 
Amy Tiersten
Consulting or Advisory Role - AstraZeneca; Eisai; Immunomedics; Novartis; Puma Biotechnology; Roche/Genentech
Research Funding - AstraZeneca; Genentech/Roche; Lilly; Novartis; pfizer